Alert detail
FDA Approval: TRELSTAR (TRIPTORELIN PAMOATE) — Type 1 - New Molecular Entity
Policy ID: FDA-NDA020715Specialty: OncologyAdded: 7/1/2026Effective: 2000-06-15billing update
Full alert analysis requires a subscription
Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.